(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 55.22% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 170.38%.
Fortress Biotech's revenue in 2026 is $63,262,000.On average, 4 Wall Street analysts forecast FBIO's revenue for 2026 to be $3,162,098,569, with the lowest FBIO revenue forecast at $2,579,521,984, and the highest FBIO revenue forecast at $3,746,446,296.
In 2027, FBIO is forecast to generate $4,444,275,858 in revenue, with the lowest revenue forecast at $3,954,796,885 and the highest revenue forecast at $4,913,145,189.